Intratumoural Injection of the Toll-Like Receptor-2/6 Agonist ‘Macrophage-Activating Lipopeptide-2’ in Patients With Pancreatic Carcinoma: A Phase I/Ii Trial
Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.26.15_suppl.15604
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2008
Authors
Publisher
American Society of Clinical Oncology (ASCO)